S.A.B.is supported by a Victorian Cancer Agency Mid-Career Research Fellowship(MCRF22003);S.F.is supported by a National Health and Medical Research Council of Australia(NHMRC)Ideas Grant(GNT1184421);R.E.has support from a Cancer Council of Western Australia Research Fellowship and a Brainchild Fellowship from the Pirate Ship Foundation;This work was supported in part through M.RJ,S.A.B.,K.P.,R.E.and,S.F.membership of the Brain Cancer Centre;K.P.is supported by an Australian Government Research Training Program Scholarship and the Ann Henderson PhD Scholarship。
Glioblastoma,a rare,and highly lethal form of brain cancer,poses significant challenges in terms of therapeutic resistance,and poor survival rates for both adult and paediatric patients alike.Despite advancements in b...
supported by the National Natural Science Foundation of China(Grant Nos.82072765 to X.Q.and 82172667 to X.W.).
Ionizing radiation is a popular and effective treatment option for glioblastoma(GBM).However,resistance to radiation therapy inevitably occurs during treatment.It is urgent to investigate the mechanisms of radioresist...
supported by the National Key Research and Development Programs of China(Grant No.2018YFA0209700);National Natural Science Foundation of China(Grant No.22077073);Frontiers Science Center for New Organic Matter,Nankai University(Grant No.63181206);the Fundamental Research Funds for the Central Universities,Nankai University(Grant No.63206015)。
Glioblastoma(GBM)is the most common malignant brain tumor.Although current treatment strategies,including surgery,chemotherapy,and radiotherapy,have achieved clinical effects and prolonged the survival of patients,the...
supported by grants from the National Natural Science Foundation of China(Nos.31970676,31970770,32270876);the National Key R&D Program of China(No.2018 YFA0800700,2022YFA0806600),and the Fundamental Research Funds for the Central Universities.
Glioblastoma multiforme(GBM),a highly malignant and heterogeneous brain tumor,contains various types of tumor and non-tumor cells.Whether GBM cells can trans-differentiate into non-neural cell types,including mural ce...
Glioblastoma(GBM)is the most aggressive primary brain tumor with a median survival of 15 months despite standard care therapy consisting of maximal surgical debulking,followed by radiation therapy with concurrent and ...
This work was supported by the Oklahoma Medical Research Foundation,and Oblato,Inc.,as reported in published manuscripts.
The poor prognosis of glioblastoma multiforme(GBM)patients is in part due to resistance to current standard-of-care treatments including chemotherapy[predominantly temozolomide(TMZ;Temodar)],radiation therapy and an a...
supported by grants from the Connecticut Partnership in Innovation and Education(PIE)Fellowship(to TL);the University of Hartford College of Arts and Sciences Dean’s Fund(to TL,FA,AOK)
Elevated levels of γ-synuclein(γ-syn)expression have been noted in the progression of glioblastomas,and also in the cerebrospinal fluid of patients diagnosed with neurodegenerative diseases.γ-Syn can be either inte...
Human cytomegalovirus (HCMV) was reported in glioblastoma multiforme (GBM) over a decade ago and this finding has the potential to increase our understanding of the disease and it offers an alternative tumor-specific ...
Objective To investigate the diagnostic value of the texture analysis derived from conventional MR imaging in differentiating glioblastomas from solitary brain metastases.Methods Thirty-four patients with pathological...
Objective: To summary the recent advances in molecular research of glioblastoma (GBM) and current trends in personalized therapy of this disease.Data Sources: Data cited in this review were obtained mainly from Pu...